Impact of intracardiac echocardiography on readmission morbidity and mortality following atrial fibrillation ablation

• DOI: 10.1111/jce.15683
• Publication Date: 2022-09-21T06:21:18Z
• Authors: Saurabh Deshpande; Hiroyuki Sawatari; Raheel Ahmed; Rakesh Gopinathan...; Hassan Khan; Mohammed Y. Khanji; Virend K. Somers; C. Anwar A. Chahal; Deepak Padmanabhan
• Keywords: Interquartile range

The use of intracardiac echocardiography (ICE) is beneficial during the ablation atrial fibrillation (AF). Evidence conflicting regarding clinical impact using ICE on arrhythmia recurrence and mortality.Patients undergoing catheter AF 2010-2017 were identified International Classification Diseases-9th 10th Revision-Clinical Modification (ICD-9-CM ICD-10-CM) from Nationwide Readmissions Database. Propensity matching was used to generate a control group. Patient demographics, Charlson comorbidity indexes, time discharge readmission, reason readmission extracted.From 2010 2017, 51 129 patients included in analysis out which 8005 (15.7%) patients. in-hospital mortality at significantly higher without (2.9% vs. 1.7%, p = .02). length stay (LOS) non-ICE arm (median [interquartile range, IQR]: 3 [2-6] 2 [3-5] days, < .0001) with similar healthcare-associated cost (HAC) both groups [IQR]: US$7507.3 [4057.8-15 474.2] 7339.4 [4024.8-15 191.6], .43). Freedom 12% (hazard ratio [HR] [95% confidence interval, CI]: 0.88 [0.83-0.94], 90-day follow-up, driven by 24% reduction heart failure (HF) follow-up (HR 0.76 [0.60-0.96], .02).ICE procedure reduces readmissions 90 days 12%, decrease HF-related admissions. showed LOS offsets marginally HAC arm.